secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0001493152-24-021880
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq non-compliance notice for late Q1 2024 10-Q filing
--------------------------------------------------------------------------------

- Nasdaq notice received May 22, 2024 due to failure to file Form 10-Q for period ended March 31, 2024.
- Company must submit a plan to regain compliance by June 14, 2024, and file delinquent 10-Q by October 14, 2024.
- No immediate effect on listing or trading of OCEA common stock or OCEAW warrants, but further delays could impact.
- Ocean Biomedical cites previously disclosed delays from its 2023 10-K as the cause.
- Company intends to file the delinquent Form 10-Q as soon as practicable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224021880/0001493152-24-021880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224021880/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer